Life Sciences Archivi - Pagina 9 di 16

23 agosto 2023

North America Leads Medical Gases and Equipment Industry

The medical gases and equipment industry will touch USD 33.84 billion by 2030, powering at a rate of 7.20%, as stated by a market research institution, P&S Intelligence, in one of its reports.

This is chiefly credited to the increasing incidence of chronic diseases globally. Furthermore, the spur in the size of the home healthcare industry, on top of tech- advancements, will boost the progress of the industry in the years to come.

Oxygen had the largest share, in the recent past, as a result of the occurrence of a large population of the patients suffering from respiratory ailments, including COPD, along with cardiac arrest, trauma, and severe bleeding. Furthermore, pure oxygen is put to use for the restoration of the tissue oxygen tension.

Also, the increasing patient count, which are in need of emergency care and ambulatory surgeries is thriving the advance of the category. Further, for the treatment of intoxication of a harmful substance and severe hypoxia, 100% oxygen must be directed through a face mask.

So, owing to the life-saving capability of O2, the category will continue to rule the segment in the years to come.

The therapeutic application dominated the market, with of over 40% share, in the past. This is as a result of the increasing usage of oxygen, medical air, nitric oxide, carbon dioxide, and helium as medication for the treatment of numerous conditions.

Moreover, medicinal oxygen is extensively employed in healthcare settings globally as complementary to anesthetic agents and in inhalation therapy. Furthermore, nitrous oxide is high in requirement in hospitals for use as an anesthetic, analgesic, and refrigerant in cryosurgical processes.

Hospitals had the largest share of over 27% in the industry. This is because of the increasing count of hospitals in both developed along with developing nations and their wide acceptance of carbon dioxide, liquid nitrogen, nitrogen protoxide, and medicinal air in ICUs, emergency rooms, and surgical rooms.

North America dominated the medical gases and equipment market with a share of over 35%, as a result of the increasing use of the related gases for the treatment along with CVD management, asthma, and COPD in hospitals, together with the high incidence of these ailments.

Moreover, the U.S. had the higher sales value, driven by the existence of a number of healthcare facilities. Also, because of the current growth in the usage of home-based therapy, the medical gas industry in the U.S. is facing a rise in standards, examination, and delivery processes.

Due to the increasing prevalence of pulmonary diseases all over the world, the demand for medical gases and equipment will continue to grow in the years to come.

21 agosto 2023

North America Leads Orthodontic Supplies Industry

The field of dentistry known as orthodontics focuses on the identification, avoidance, and correction of misaligned jaws, teeth, and bite patterns. Dentofacial orthopedics, or the control of facial development, may also be a topic.

It’s fairly common to have misaligned teeth and jaws. The goal of orthodontic treatment is to gradually change the position of the teeth and the alignment of the jaw over the course of several months to many years using braces and other devices.

Jaw surgery could be advised as a course of therapy for severe malocclusions. Because developing bones can change more easily than mature ones, treatment is typically started before an individual reaches adulthood.

According to a report by P&S Intelligence, the orthodontic supplies market is expected to reach USD 11,214 million by 2030. This is because of the growth in the prevalence of malocclusion globally and the increased attention being paid to therapies that are affordable.

Largest Market for Such Supplies Is in North America

Due to the increasing prevalence of dental problems, North America, which controlled 38.1% of the market, has the biggest demand for these products. In addition, the burgeoning presence of major competitors and growing knowledge of the treatments on offer are anticipated to be key factors in the expansion of the North American orthodontic supplies sector.

Additionally, the U.S. controlled the sector in North America. This is attributed to an improvement in the dental care system, rising disposable money, and an increase in the popularity of cosmetic orthodontic procedures.

Moreover, 85% of Americans are very worried about their oral health, as per the American Dental Association, as of June 2021. Thus, the need for cosmetic braces is growing as a result of patients’ growing worries about this requirement.

21 agosto 2023

Nerve Repair and Regeneration Industry Development and Demand Forecast to 2030

The nerve repair and regeneration market will reach over USD 17.47 billion, growing at a 12.2% CAGR, by 2030.

The growth of the industry is mainly credited to the increasing incidence of traumatic brain injuries, along with numerous neurological illnesses, for instance, ataxia, Alzheimer’s disease, and acute spinal cord injury. Additionally, the rising government organization’s support for research on nervous system disorders will further boost the growth of the industry in the years to come.

Furthermore, developing nations, such as Brazil, China, and India are providing profitable growth opportunities for the expansion of the domain. This is attributed to the mounting incidence of neurological disorders, increasing healthcare expenses, and the large population in these nations.

In 2021, the neurostimulation/neuromodulation devices category, based on product, accounted for the largest industry share, of over 64%. This is mainly because of the growing commercialized spinal cord stimulation product numbers, itself because of the increasing number of individuals with spinal cord injuries. Additionally, the technological progressions, the biocompatibility of these devices, and the increasing number of applications are boosting the category growth.

The APAC industry will observe the fastest growth rate, of over 13%, in the years to come. This is because of the mounting elderly population, increasing healthcare expenses, and the rising incidence of neurological illnesses, for instance, Parkinson’s, epilepsy, Alzheimer’s, and essential tremors. Additionally, the implementation of advanced technologies for the treatment of these illnesses is boosting the growth in this region.

In APAC, the nerve regeneration and repair therapies adoption in China, Japan, and India is advancing rapidly because of the growing healthcare infrastructure rate and new technology penetrations.

Hence, with the increasing incidence of traumatic brain injuries and rising research on nervous system disorders, the nerve repair and regeneration industry will advance significantly in the coming years.

17 agosto 2023

Robotic Surgery Is Paving Way for a Healthcare Revolution

The global surgical robots market was worth around $6,281.1 million in 2021, which is predicted to touch $30,067.2 million by 2030, growing at a 19% CAGR from 2021 to 2030. This might be related to the rising demand for hip and knee surgery, as well as technical advances. Hospitals reduced or canceled non-urgent outpatient visits during the epidemic. However, with more procedures being performed throughout the world in the future years, the industry is projected to recover and grow more.

Robotic surgery has effectively overcome the constraints of old laparoscopic and thoracoscopic surgeries, enabling more precise execution of complicated and sophisticated surgical operations in a less invasive manner. The surgeon is situated easily on the robotic control console, as opposed to the uncomfortable postures necessary for laparoscopic surgery, which decreases the physician’s physical strain. In addition, as compared to standard laparoscopic devices, manipulating robotic arm instruments enhances the range of motion, allowing the surgeon to conduct more complicated surgical operations.

During the projection period, the surgical robots market is expected to grow at the fastest pace in the neurology category, with a CAGR of roughly 21%. The increasing use of surgical robots for treating patients with tumors and other brain problems can be ascribed to improved technology in robotic brain surgeries and the increasing use of surgical robots for treating patients with tumors and other brain conditions. Furthermore, due to the rising frequency of neurological illnesses and growing need for minimally invasive procedures for executing delicate brain surgeries, the industry in this category is developing.

For example, utilizing DBS technology, the University of California San Francisco devised a way to treat depression symptoms. Electrodes are implanted in the brain to provide electrical currents that change brain function. This form of automated on-demand therapy has a long-term impact on the patient’s condition. Furthermore, in 2021, university researchers produced a new type of voice neuroprosthesis for paralyzed individuals. It will benefit individuals who have a severely injured central nervous system, which can cause paralysis throughout the body.

During the projection period, the APAC surgical robots market is expected to develop at the fastest pace of 20.7%. This can be attributed to rising demand for less invasive procedures to shorten recovery times, a significant presence of international rivals, and increasing robotics advances. Furthermore, prominent firms invest in R & D, to reduce the cost of innovative surgery procedures and accelerate their clinical adoption. In addition, more positive results compared to open procedures, as well as a shorter hospital stay and recovery time for patients, are driving up the need for robotic-assisted surgeries.

Surgical robots have grown in popularity in recent years, both in terms of research and testing, and in terms of use in ordinary treatment including shoulder, foot & ankle, elbow, hand & wrist, and neck. Employing robot arms controlled by a computer, surgeons may perform less invasive treatments with greater precision. Furthermore, as the benefits of minimally invasive surgery become more widely accepted and used, including shorter hospital stays, reduce blood loss, and less pain, new industry participants are launching cost-effective and sophisticated surgical robots.

Hence, the advancing frequency of neurological illnesses and rising demand for minimally invasive treatments are growing for surgical robots.

11 agosto 2023

Asia-Pacific Grew the Fastest in Sleep Apnea Devices Industry

As per a report published by a market research institution, P&S Intelligence, the sleep apnea devices industry will grow at a compound annual growth rate of 7.2%, to touch USD 13,386.5 million by 2030.

This growth of the industry is because of the increasing incidence of OSA, unhealthy routines of individuals, changes in diet and sleep patterns, and enormous work pressure.

With the development of cutting-edge products, there is an increase in the acceptance of portable devices. For example, products equipped with additional features, for example the usage of an algorithm and pressure sensor for determination of the best pressure, are there in the market.

Therapeutic devices had the larger share. The industry has availability of numerous therapeutic devices for treating sleep apnea in which sleeping aids support the treatment. It will also be faster growing category, advancing at a rate of about 9% by the end of this decade. This growth will mainly be led by the growing OSA cases globally.

North America led the sleep apnea devices market, with about 45% share in 2022. This is because of the increasing incidence of sleeping ailments. Also, the rise in the incidence of a number of health conditions, for example obesity and heart diseases, which are risky factors for sleep apnea will also play a part in the growth of the industry in the region.

The growing elderly population also plays a key role in powering the market growth. With elderly, people suffer from health issues, as a result of psychological features and changes in cardiac rhythm, therefore making them more vulnerable to sleep ailments.

Furthermore, OSA and insomnia are the most common sleeping conditions in aged people. For improving the quality of life and ensuring a healthy lifestyle amongst the elderly population, the requirement for such devices is rapidly on the rise.

The increasing incidence of OSA, and the changing lifestyle of the people has a lot to do with the increasing demand for sleep apnea devices all over the world.

10 agosto 2023

United States Medical Equipment Maintenance Industry was Dominated by Texas

U.S. Medical Equipment Maintenance Industry

The United States medical equipment maintenance market will power at a rate of 9.2% in the years to come, to reach USD 21,358.3 million by 2030, as stated by a market research institution, P&S Intelligence.

This growth will be driven by the progressions in the medical device industry, increasing consciousness on preventive medical equipment upkeep, and a strict regulatory environment.

Preventive maintenance dominated the industry. This will also have the highest growth rate in the years to come. This can be credited to the growing acceptance of AMC policies by hospitals and other users in the nation, because of the numerous reimbursements related to them.

Private-sector organizations will have the larger share in 2030. This has a lot to do with the budding private-sector healthcare sector and increasing healthcare spending.

Among all the states, Texas dominated the industry in the past, and it is expected to grow the fastest in the years to come.

This is mainly due to the presence of a high number of hospitals in the state, coupled with the growing healthcare expenditure. State agencies, such as the HHSC, DADS, and Texas DSHS, had ~83% of all healthcare expenditure in the state on an annual basis.

The users in the medical equipment maintenance market of the nation are becoming more persuaded toward entering into multi-vendor contracts, for reducing the intricacies and further expenses related to separate services delivered under agreements with the builders of medical equipment.

In the country, numerous tech advanced medical devices and associated products are put to use by healthcare specialists and governments to offer best in-class amenities to patients.

As these high-tech medical devices necessitate steady maintenance, software updates, and other kinds of services, their snowballing acceptance will drive the market in the years to come.

The U.S. has a strict regulatory framework, which makes the maintenance of medical equipment a compulsory requirement for users.

According to the regulations, hospitals must follow OEMs suggest preventive maintenance procedures and programs, unless a waiver was executed and accepted by the health department.

With these kinds of regulations in place, the acceptance of medical equipment upkeep services by hospitals and other healthcare facilities will increase, powering the market in the near future.

This market is highly diversified, because of the occurrence of more than a few key players. Recently, major players have taken a number of strategic measures, for example partnerships, mergers and accusations , and facility developments, to gain a competitive edge in the market.

It is because of the growing consciousness on preventive medical equipment upkeep, the demand for medical equipment maintenance, will increase in the years to come in the U.S.

7 agosto 2023

North America Is Dominating Embolotherapy Industry

The global embolotherapy market is experiencing growth and is projected to reach 6,447.1 million by 2030, according to P&S Intelligence. This growth can be ascribed to the rising patient pool, mounting occurrence of chronic and lifestyle-related illnesses, growing healthcare investments, and advancing healthcare infrastructure.

In recent years, embolic agents led the industry, on the basis of product. The growing utilization of embolic agents in numerous interventional radiology procedures is the major factor for this product category’s supremacy in the industry.

Moreover, because of the improvements in such agents, including drug-eluting microspheres, standardized microspheres for bland embolization, and radioactive yttrium-90 (Y-90) microspheres, for curing primary or secondary liver illness, the category is projected to advance at a higher rate in the coming few years.

In the coming few years, the transcatheter arterial embolization category is projected to be the fastest-rising category, on the basis of procedure. This can be credited to the thriving requirement for minimally invasive procedures and the quickly rising elderly populace.

Furthermore, TAE is effective and well-tolerated in patients with ruptured hepatocellular carcinoma (HCC), and it is favored over transarterial radioembolization (TARE) and transarterial chemoembolization (TACE).

In recent years, North America led the embolotherapy market, and it is projected to grip the largest industry share in the future as well. The growing occurrence of signs that need embolization procedures, well-known healthcare infrastructure, and the growth of progressive embolic agents by the players functioning in the continent are some of the key factors for the development of the North American industry.

The embolotherapy industry is experiencing development mainly because of the surge in the count of patients looking for embolization for the treatment of HCC, aneurysms, renal cell carcinoma (RCC), and varicose veins.

As per the Centers for Disease Control and Prevention (CDC), in 2018, aortic aneurysms were accountable for 9,923 demises in the U.S., which displays the unmet medicinal requirement for these procedures. Thus, the growing patient pool fortifies the requirement for embolization procedures.

The extended exposure to four modifiable lifestyle behaviors, mainly physical inactivity, smoking, alcohol consumption, and unhealthy diet, commonly results in chronic illnesses, such as diabetes, stroke, metabolic syndrome, obesity, chronic obstructive pulmonary illness, and numerous kinds of cancer.

Chronic illnesses are a key healthcare load impacting high-income as well as low- and middle-income nations (LMICs). Hepatitis, cancer, and central nervous system syndromes are some of the chronic illnesses that need progressive treatment. Therefore, the surge in the occurrence of chronic and lifestyle-related illnesses is boosting the embolotherapy industry worldwide.

Hence, the growing patient pool, mounting occurrence of chronic and lifestyle-related illnesses, growing healthcare investments, and advancing healthcare infrastructure, such factors are propelling embolotherapy market.

4 agosto 20234 agosto 2023

APAC To Observe Fastest Growth In the Private Healthcare Insurance Industry

As per a report by P&S Intelligence the healthcare insurance market is growing rapidly, and it will continue like this in the years to come. This is mainly attributed to the increasing elderly population, rising gross domestic product and healthcare expenses, and growing prevalence of chronic illnesses across the world.

Private healthcare insurance companies provide a variety of plans for disease, income protection, and medical. Medical insurance denotes the policy of health insurance that covers high deductible medical expenses. This policy covers specific expenses on a limited amount, for instance, emergency services, ambulatory patient services, and hospital bed expenditures.

Some prominent international players in the private healthcare insurance industry include AXA Group, Allianz SE, Aetna Inc., Aviva plc, Cigna Corporation, Zurich Insurance Group, GIE BNP Paribas Cardif, Continentale Krankenversicherung a.G, Assicurazioni Generali S.p.A., and British United Provident Association Limited. These companies are present in Germany, the U.S., France, Spain, Italy, the United Kingdom, China, Switzerland, Japan, Australia, India, Mexico, and Brazil.

Established in 1890, Allianz SE is an insurance provider that operates in 70 countries worldwide. The company offers insurance products and services through its three main segments: health/life insurance, asset management, and property-casualty insurance.

AXA Group, established in 1982, is an insurance company that operates across six distinct segments: Asia, France, the U.S., Europe, transversal and central holdings, and international. The group provides a wide range of products and services across multiple categories, including life and savings, health, property and casualty, banking, and asset management.

The U.S., China, India, Japan, France, Germany, Italy, the U.K., Spain, Switzerland, Australia, Mexico, and Brazil have well-established insurance networks of international players. Additionally, government-mandated insurance policies play a crucial role in driving the growth of both the private and public healthcare insurance industry.

The global private healthcare insurance industry will observe the fastest growth in APAC, particularly in China, India, Australia, and Japan. This growth can be attributed to several factors, such as the increasing healthcare insurance industry, the mounting incidence of chronic illnesses, and rising consciousness regarding healthcare in the region. The growth of the medical tourism industry also contributes to the development of the industry in APAC.

Some of the key players in APAC include Allianz SE, AXA Group, Ping An Insurance (Group) Company of China Ltd., China Life Insurance Co. Ltd., Aetna International, Nippon Life Insurance Company, Allianz SE, Star Health & Allied Insurance Company Limited, Religare Health Insurance Company, and ICICI Lombard General Insurance.

Moreover, the overall dynamics of the healthcare insurance industry in the APAC are undergoing significant changes, driven by improvements in healthcare infrastructure and expenses. As a result, healthcare insurance plans are becoming popular among people in Asia.

Hence, with the increasing elderly population and mounting prevalence of chronic illnesses across the world, the industry of private healthcare insurance will continue to grow in the years to come.

3 agosto 2023

Why Is Autoimmune Disease Diagnostics Demand Rising Robustly?

The Multiple Sclerosis International Federation (MSIF) states that 2.8 million people around the globe were living with multiple sclerosis in 2020, and this autoimmune disease affects around 1 in 3,000 people worldwide. Further, the American Lung Association estimates that approximately 200,000 new cases of sarcoidosis are recorded in the U.S. each year. Additionally, the National Organization for Rare Disorders states that 1 in 10,000 individuals around the world are affected by systemic scleroderma, and this autoimmune disorder is highly prevalent among the Australian and North American populations.

Thus, the increasing prevalence of autoimmune disorders is expected to drive the autoimmune disease diagnostics market at a CAGR of 8.5% during the forecast period 2020–2030. According to P&S Intelligence, the market was valued at $4,086.2 million in 2019, and it will generate $10,012.9 million revenue by 2030. The market growth is also facilitated by the rising public awareness regarding such diseases and the increasing number of awareness programs being organized by public and private organizations to impart knowledge about such disorders.

In recent years, several researchers have discovered new biological markers or biomarkers to diagnose autoimmune diseases. For example, in August 2019, researchers at the University of Alberta discovered a new biological marker to identify the existence of myasthenia gravis, a rare autoimmune disease. This biomarker can also be utilized for formulating new personalized treatment procedures and predicting the course of the disease. Scientists around the world are also discovering biomarkers to detect multiple sclerosis, rheumatoid arthritis (RA), sarcoidosis, scleroderma, systemic lupus erythematosus (SLE), and sjögren’s syndrome.

The product segment of the autoimmune disease diagnostics market is bifurcated into instruments, and consumables and assay kits. Of these, the consumables and assay kits category generated a higher revenue during the historical period (2014–2019), and it is expected to retain its dominance in the forecast years as well. This can be ascribed to the surging incidence of autoimmune diseases and the rising number of research activities to identify the cause of such diseases.

These autoimmune disease diagnostic products are used in academic institutes and research centers, hospitals, and diagnosing centers in autoantibodies and immunology, cytokine, flow cytometry, human leukocyte antigen (HLA), inflammatory marker, and routine laboratory tests. Currently, hospitals are the largest user of such products, owing to the improving healthcare infrastructure, the rising prevalence of chronic autoimmune disorders, the soaring number of awareness programs and campaigns being conducted by public and private organizations, and the increasing deployment of technologically advanced medical devices by these healthcare facilities.

Globally, the North American autoimmune disease diagnostics market generated the highest revenue during the historical period, on account of the mounting healthcare expenditure, soaring aging population, and increasing cases of autoimmune diseases in the region. Additionally, the presence of leading market players also contributes to the regional market growth. Whereas, the Asia-Pacific market is expected to display the fastest growth throughout the forecast period, owing to the booming elderly population and mounting public awareness regarding autoimmune diseases in regional countries.

Therefore, the surging burden of autoimmune diseases and the growing public awareness about such disorders will facilitate the adoption of autoimmune disease diagnostic products, globally.

2 agosto 2023

Medical Gloves Industry To Observe Fastest Growth In Asia-Pacific

As per a statement by P&S Intelligence, the medical gloves industry will reach USD 20,435.6 million, propelling at a rate of 10.8%, by 2030.

The growth in the industry is credited to the increasing elderly population, the growing risk of contagious diseases, mounting healthcare expenses, the growing volume of surgeries, and the increasing incidence of chronic diseases.

The medical gloves industry had been positively affected by the COVID-19 pandemic, due to the sudden surge in medical supplies demand.

Based on raw materials, the nitrile category held the largest share of the medical gloves industry in recent years. This is mainly due to its non-allergic properties.

North America is expected to dominate the industry in the years to come, owing to the widespread necessity for medical gloves in healthcare units, and the existence of strong key players.

Moreover, APAC is expected to witness the fastest growth in the coming years, owing to the increasing elderly populace and rising number of surgical procedures and diagnostic examinations.

A key trend observe in the industry is the fondness for non-powdered medical gloves over powdered medical gloves by the customers, due to the non-allergic properties of the non-powdered medical gloves.

In the past few years, players in the industry have been involved in product launches and mergers & acquisitions to maintain a competitive edge.

Hence, due to the increasing elderly pullulation, increasing incidence of chronic diseases, and growing risk of contagious diseases, the medical gloves industry will continue to grow significantly in the years to come.